02/08/2023Immunome Announces Formation of Antibody-Drug Conjugate and T Cell Redirection Advisory Board
01/06/2023AbbVie and Immunome Announce Strategic Collaboration to Discover Multiple Novel Oncology Targets
11/09/2022Immunome Presents Preclinical Data on Novel Anti-EPN1 Antibody IMM20059 at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
11/07/2022Immunome Presents Preclinical Data on Novel Anti-EPN1 Antibody IMM20059 at the Society for Immunotherapy of Cancer’s (SITC) 37th Annual Meeting
08/23/2022Immunome Announces Publication in Clinical & Translational Immunology Highlighting B Cell Repertoires in Patients with Breast Cancer
07/06/2022Immunome’s COVID-19 Cocktail Retains Neutralizing Activity Against the Most Prevalent Omicron Subvariants* in the US, BA.4/5 and BA.2.12.1